{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:08:09Z","timestamp":1767902889810,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intermittent preventive treatment of malaria in pregnancy (IPTp) is a comprehensive treatment protocol of anti-malarial drugs administered to pregnant women to prevent malaria, started at the fourth pregnancy month, with at least three doses of sulfadoxine\u2013pyrimethamine (SP), taken as directly observed treatment (DOT) every 30\u00a0days at intervals until childbirth, in combination with other preventive measures. This paper introduces feasibility and adoption concepts as implementation research outcomes (IRO), allowing after a defined intervention, to assess the coverage improvement by IPTp for women attending a reference district hospital in Mali. Specifically, the purpose is to evaluate the feasibility of a reminder tool (provider checklist) to enhance pregnant women\u2019s adoption of information about IPTp-SP uptake as immediate and sustained women practices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The implementation strategy used a reminder checklist about malaria knowledge and the recommended preventive tools. Then, the checklist feasibility was assessed during routine practices with the adoption-level about pregnant women\u2019 knowledge. Quantitative data were collected through a questionnaire distributed to a non-probability purposive sampling targeting 200 pregnant women divided into two groups before and after the checklist intervention. In contrast, the qualitative data were based on in-depth face-to-face gynaecologists\u2019 interviews.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Both the IROs (feasibility and adoption) were satisfactory. The gynaecologists agreed to the use of this checklist during routine practice with a recommendation to generalize it to other health providers. After a gynaecologist visit, a significant increase of the adoption-level about prior knowledge and preventive tools was noticed. A total of 83% of participants were not knowledgeable about malaria disease before checklist use <jats:italic>versus<\/jats:italic> 15% after. Similarly, coverage of women\u2019s SP DOT rose from 0 to 59% after introducing the checklist and the IPTp-SP uptake after the visit was highly significant in the second group. The latter reached 95% of pregnant women with 4\u20138\u00a0months\u2019 gestational age, that mostly respected all SP future visits as theoretically scheduled.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Generalizing such a checklist reminder will improve women\u2019s knowledge about malaria prevention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-021-03940-7","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T16:53:01Z","timestamp":1634403181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The provider\u2019s checklist to improve pregnant women coverage by intermittent preventive malaria treatment in Mali: a pilot implementation study"],"prefix":"10.1186","volume":"20","author":[{"given":"Issa","family":"Doumbia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fomba","family":"Seydou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kon\u00e9","family":"Diakalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issam","family":"Bennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,16]]},"reference":[{"key":"3940_CR1","unstructured":"WHO, Global Malaria Programme. World malaria report 2019. Geneva: World Health Organization; 2019. https:\/\/www.who.int\/publications\/i\/item\/9789241565721. Accessed 26 Dec 2020."},{"key":"3940_CR2","volume-title":"Lives at risk: malaria in pregnancy","author":"WHO","year":"2013","unstructured":"WHO. Lives at risk: malaria in pregnancy. Geneva: World Health Organization; 2013."},{"key":"3940_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-319-66242-8_12","volume":"71","author":"B Anaemene","year":"2018","unstructured":"Anaemene B. Health and diseases in Africa. Dev Afr. 2018;71:207\u201326.","journal-title":"Dev Afr"},{"key":"3940_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12936-016-1261-2","volume":"15","author":"S Dellicour","year":"2016","unstructured":"Dellicour S, Hill J, Bruce J, Ouma P, Marwanga D, Otieno P, et al. Effectiveness of the delivery of interventions to prevent malaria in pregnancy in Kenya. Malar J. 2016;15:221.","journal-title":"Malar J"},{"key":"3940_CR5","unstructured":"WHO Intermittent preventive treatment in pregnancy (IPTp). Geneva: World Health Organization; 2018. https:\/\/www.who.int\/malaria\/areas\/preventive_therapies\/pregnancy\/en. Accessed 26 Dec 2020."},{"key":"3940_CR6","unstructured":"WHO. Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). Geneva: World Health Organization, 2014. p. 1\u201313. http:\/\/www.who.int\/malaria\/publications\/atoz\/policy_brief_iptp_sp_policy_recommendation\/en. Accessed 26 Dec 2020."},{"key":"3940_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12936-017-1969-7","volume":"16","author":"I Owusu-Boateng","year":"2017","unstructured":"Owusu-Boateng I, Anto F. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana. Malar J. 2017;16:323.","journal-title":"Malar J"},{"key":"3940_CR8","unstructured":"WHO. Policy recommendation: Seasonal Malaria Chemoprevention for Plasmodium falciparum control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: World Health Organization; 2012. http:\/\/www.who.int\/malaria\/publications\/atoz\/smc_report_teg_meetingmay2011.pdf. Accessed 26 Dec 2020."},{"key":"3940_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12936-016-1363-x","volume":"15","author":"HU Muhammad","year":"2016","unstructured":"Muhammad HU, Giwa FJ, Olayinka AT, Balogun SM, Ajayi I, Ajumobi O, et al. Malaria prevention practices and delivery outcome: a cro ss sectional study of pregnant women attending a tertiary hospital in northeastern Nigeria. Malar J. 2016;15:326.","journal-title":"Malar J"},{"key":"3940_CR10","unstructured":"WHO. World Malaria Report 2016. Geneva: World Health Organization; 2016. http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2016\/en. Accessed 26 Dec 2020."},{"key":"3940_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1475-2875-8-25","volume":"8","author":"L Brabin","year":"2009","unstructured":"Brabin L, Stokes E, Dumbaya I, Owens S. Rural Gambian women\u2019s reliance on health workers to deliver sulphadoxine-pyrimethamine as recommended intermittent preventive treatment for malaria in pregnancy. Malar J. 2009;8:25.","journal-title":"Malar J"},{"key":"3940_CR12","first-page":"e01198848","volume":"10","author":"J Hill","year":"2015","unstructured":"Hill J, Kayentao K, Achieng F, Diarra S, Dellicour S, Diawara SI, et al. Access and use of interventions to prevent and treat malaria among pregnant women in Kenya and Mali: a qualitative study. PLoS ONE. 2015;10:e01198848.","journal-title":"PLoS ONE"},{"key":"3940_CR13","unstructured":"Institut National de la Statistique - INSTAT, Cellule de Planification et de Statistique Secteur Sant\u00e9-D\u00e9veloppement, and ICF. Mali Demographic and Health Survey 2018. Bamako, Mali: INSTAT\/CPS\/SS-DS-PF and ICF; 2019. http:\/\/dhsprogram.com\/pubs\/pdf\/FR358\/FR358.pdf."},{"key":"3940_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S1473-3099(10)70295-4","volume":"11","author":"AM Van Eijk","year":"2011","unstructured":"Van Eijk AM, Hill J, Alegana VA, Kirui V, Gething PW, ter Kuile FO, et al. Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data. Lancet Infect Dis. 2011;11:190\u2013207.","journal-title":"Lancet Infect Dis"},{"key":"3940_CR15","doi-asserted-by":"publisher","first-page":"e0160008","DOI":"10.1371\/journal.pone.0160008","volume":"11","author":"EA Hurley","year":"2016","unstructured":"Hurley EA, Harvey SA, Rao N, Diarra NH, Klein MC, Diop SI, et al. Underreporting and missed opportunities for uptake of intermittent preventative treatment of malaria in pregnancy (IPTp) in Mali. PLoS ONE. 2016;11:e0160008.","journal-title":"PLoS ONE"},{"key":"3940_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38:65\u201376.","journal-title":"Adm Policy Ment Health"},{"key":"3940_CR17","doi-asserted-by":"publisher","first-page":"i6795","DOI":"10.1136\/bmj.i6795","volume":"356","author":"H Pinnock","year":"2017","unstructured":"Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for reporting implementation studies (StaRI) statement. BMJ. 2017;356:i6795.","journal-title":"BMJ"},{"key":"3940_CR18","doi-asserted-by":"publisher","DOI":"10.4135\/9781526417190","volume-title":"Integrating analyses in mixed methods research","author":"P Bazeley","year":"2018","unstructured":"Bazeley P. Integrating analyses in mixed methods research. London: Sage; 2018."},{"key":"3940_CR19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.4269\/ajtmh.2010.09-0339","volume":"82","author":"LL Sabin","year":"2010","unstructured":"Sabin LL, Rizal A, Brooks MI, Singh MP, Tuchman J, Wylie BJ, et al. Attitudes, knowledge, and practices regarding malaria prevention and treatment among pregnant women in eastern India. Am J Trop Med Hyg. 2010;82:1010\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"3940_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/07399332.2016.1234483","volume":"38","author":"G Danhoundo","year":"2017","unstructured":"Danhoundo G, Wiktorowicz ME, Yaya S. Governance of malaria prevention: how decision-makers\u2019 and pregnant women\u2019s sensemaking contribute to unintended consequences. Health Care Women Int. 2017;38:238\u201352.","journal-title":"Health Care Women Int"},{"key":"3940_CR21","doi-asserted-by":"publisher","first-page":"e0203740","DOI":"10.1371\/journal.pone.0203740","volume":"14","author":"P Arnaldo","year":"2019","unstructured":"Arnaldo P, Cambe MI, Maga\u00e7o A, Chicumbe S, Rovira-Vallbona E, Rosanas-Urgell A, et al. Access to and use of preventive intermittent treatment for malaria during pregnancy: a qualitative study in the Ch\u00f3kw\u00e8 district, Southern Mozambique. PLoS ONE. 2019;14:e0203740.","journal-title":"PLoS ONE"},{"key":"3940_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4103\/1596-3519.68352","volume":"9","author":"AU Gajida","year":"2010","unstructured":"Gajida AU, Iliyasu Z, Zoakah AI. Malaria among antenatal clients attending primary health care facilities in Kano state, Nigeria. Ann Afr Med. 2010;9:188\u201393.","journal-title":"Ann Afr Med"},{"key":"3940_CR23","first-page":"105","volume":"14","author":"S Bamba","year":"2013","unstructured":"Bamba S, S\u00e9r\u00e9 A, Niki\u00e9ma R, Halidou T, Thi\u00e9ba B, Dao B, et al. Traitement pr\u00e9ventif intermittent \u00e0 la sulfadoxine-pyrim\u00e9thamine du paludisme chez les femmes enceintes: Efficacit\u00e9 et observance dans deux h\u00f4pitaux urbains du Burkina Faso. Pan Afr Med J. 2013;14:105.","journal-title":"Pan Afr Med J"},{"key":"3940_CR24","doi-asserted-by":"publisher","first-page":"e67520","DOI":"10.1371\/journal.pone.0067520","volume":"8","author":"J Webster","year":"2013","unstructured":"Webster J, Kayentao K, Bruce J, Diawara SI, Abathina A, Haiballa AA, et al. Prevention of malaria in pregnancy with intermittent preventive treatment and insecticide treated nets in Mali: a quantitative health systems effectiveness analysis. PLoS ONE. 2013;8:e67520.","journal-title":"PLoS ONE"},{"key":"3940_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12856\/JHIA-2017-v4-i1-154","volume":"4","author":"A Camara","year":"2017","unstructured":"Camara A, Dian M, Diallo D, Guilavogui T. Facteurs associ\u00e9s \u00e0 l\u2019utilisation du traitement pr\u00e9ventif intermittent par la femme enceinte en Guin\u00e9e: une analyse des donn\u00e9es de l\u2019enqu\u00eate EDS 2012. J Health Inform Afr. 2017;4:1\u201311. https:\/\/doi.org\/10.12856\/JHIA-2017-v4-i1-154.","journal-title":"J Health Inform Afr"},{"key":"3940_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3917\/spub.151.0099","volume":"27","author":"J Tiendreb\u00e9ogo","year":"2015","unstructured":"Tiendreb\u00e9ogo J, Drabo MK, Saizonou J, Soglohoun CT, Para\u00efso NM, Si\u00e9 A, et al. Facteurs associ\u00e9s \u00e0 la faible couverture du Traitement Pr\u00e9ventif Intermittent chez les femmes enceintes de la zone sanitaire b\u00e9ninoise de Pob\u00e8-Adja-Ou\u00e8r\u00e8-K\u00e9tou. Sante Publique (Paris). 2015;27:99.","journal-title":"Sante Publique (Paris)"},{"key":"3940_CR27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12936-016-1627-5","volume":"15","author":"D Almond","year":"2016","unstructured":"Almond D, Madanitsa M, Mwapasa V, Kalilani-Phiri L, Webster J, Ter Kuile F, et al. Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi. Malar J. 2016;15:574.","journal-title":"Malar J"},{"key":"3940_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12936-021-03764-5","volume":"20","author":"O Sangho","year":"2021","unstructured":"Sangho O, Tounkara M, Whiting-Collins LJ, Beebe M, Winch PJ, Doumbia S. Determinants of intermittent preventive treatment with sulfadoxine\u2013pyrimethamine in pregnant women (IPTp-SP) in Mali, a household survey. Malar J. 2021;20:231.","journal-title":"Malar J"},{"key":"3940_CR29","unstructured":"Jhpiego. Prevention and Control of Malaria in Pregnancy Reference Manual; 2018. http:\/\/resources.jhpiego.org\/system\/files\/resources\/01_MIPReferenceManual_ANC.pdf. Accessed 26 Dec 2020."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03940-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-021-03940-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03940-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T16:55:03Z","timestamp":1634403303000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-021-03940-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3940"],"URL":"https:\/\/doi.org\/10.1186\/s12936-021-03940-7","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,16]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol\u2019s approval was obtained on 17 February 2018 from the National Ethics Committee for Health and Life Sciences in Mali under the identification N\u00b0 003\/MSHP-CNESS. The study administrative authorization was provided by the Bamako District Regional Health Directorate and the District Hospital of Commune VI\u2019s Chief Medical Officer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}